- Citations, last 5 years
- 0
- Works, last 5 years
- 0
- h-index
- 23
- Scientists listed
- 0
- Grants since 2016
- 1
Grants received
2021–2025 · research · R41
AlgenML: Drug target discovery platform for transcriptional reprogramming of MYCN-driven neuroblastoma
Chun-Hao Huang · Evergen Biotechnologies (United States) · funded by National Institutes of Health